To determine the degree of the contribution that the PTEN-mutated group has in the positive correlation previously observed between PI3K-AKT-mTOR genetic signatures and NFE2L2 expression in T-ALL, we investigated the enrichment of this pathway only in those cases not exhibiting PTEN loss-of-function mutations. This evidence concerns the gene AKT1 and acute lymphoblastic leukemia.